AU2002349271A1 - Use of active substances for the prophylaxis and/or treatment of diseases caused by cell growth disturbances and test system for discovery of said active substances - Google Patents

Use of active substances for the prophylaxis and/or treatment of diseases caused by cell growth disturbances and test system for discovery of said active substances

Info

Publication number
AU2002349271A1
AU2002349271A1 AU2002349271A AU2002349271A AU2002349271A1 AU 2002349271 A1 AU2002349271 A1 AU 2002349271A1 AU 2002349271 A AU2002349271 A AU 2002349271A AU 2002349271 A AU2002349271 A AU 2002349271A AU 2002349271 A1 AU2002349271 A1 AU 2002349271A1
Authority
AU
Australia
Prior art keywords
active substances
prophylaxis
discovery
treatment
cell growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002349271A
Other languages
English (en)
Inventor
Wilfried Rossoll
Michael Anton Sendtner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medinnova Gesellschaft fuer Medizinische Innovationen aus Akademischer Forschung mbH,
Original Assignee
Medinnova Gesellschaft fuer Medizinische Innovationen aus Akademischer Forschung mbH,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medinnova Gesellschaft fuer Medizinische Innovationen aus Akademischer Forschung mbH, filed Critical Medinnova Gesellschaft fuer Medizinische Innovationen aus Akademischer Forschung mbH,
Publication of AU2002349271A1 publication Critical patent/AU2002349271A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002349271A 2001-09-25 2002-09-19 Use of active substances for the prophylaxis and/or treatment of diseases caused by cell growth disturbances and test system for discovery of said active substances Abandoned AU2002349271A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10147088.6 2001-09-25
DE2001147088 DE10147088A1 (de) 2001-09-25 2001-09-25 Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Erkrankungen, die mit Zellwachstumsstörungen einhergehen und Testsystem zum Auffinden solcher Wirksubstanzen
PCT/DE2002/003576 WO2003027317A2 (de) 2001-09-25 2002-09-19 Verwendung von wirksubstanzen zur prophylaxe und/oder therapie von erkrankungen, die mit zellwachstumsstörungen einhergehen und testsystem zum auffinden solcher wirksubstanzen

Publications (1)

Publication Number Publication Date
AU2002349271A1 true AU2002349271A1 (en) 2003-04-07

Family

ID=7700131

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002349271A Abandoned AU2002349271A1 (en) 2001-09-25 2002-09-19 Use of active substances for the prophylaxis and/or treatment of diseases caused by cell growth disturbances and test system for discovery of said active substances

Country Status (4)

Country Link
EP (1) EP1432816A2 (de)
AU (1) AU2002349271A1 (de)
DE (1) DE10147088A1 (de)
WO (1) WO2003027317A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107828814A (zh) * 2017-09-08 2018-03-23 信雅生物科技（苏州）有限公司 一种表达重组人nlk基因的质粒及构建方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19844003A1 (de) * 1998-09-25 2000-03-30 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
DE19924401A1 (de) * 1999-05-27 2000-11-30 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
IL151079A0 (en) * 2000-02-07 2003-04-10 Quark Biotech Inc Fas pathway genes
WO2001059080A1 (en) * 2000-02-11 2001-08-16 Millennium Pharmaceuticals, Inc. 18477, a human protein kinase and uses therefor
WO2002066021A2 (de) * 2001-02-22 2002-08-29 Universitätsklinikum Charite Medizinische Fakultät Der Humboldt-Universität Zu Berlin Inhibitoren der protein kinase d und der protein kinase 2 als mittel zur hemmung von tumorzellen und zur stimulierung der angiogehese

Also Published As

Publication number Publication date
WO2003027317A2 (de) 2003-04-03
EP1432816A2 (de) 2004-06-30
WO2003027317A3 (de) 2003-05-22
DE10147088A1 (de) 2003-04-17

Similar Documents

Publication Publication Date Title
IL152985A0 (en) Substituted bicyclic derivatives for the treatment of abnormal cell growth
HUP0501069A2 (en) Quinazoline derivatives for the treatment of abnormal cell growth
AU2003288603A1 (en) Pyrimidine derivates for the treatment of abnormal cell growth
AU4860900A (en) Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
IL172047A0 (en) Pyrimidine derivatives for the treatment of abnormal cell growth
AUPP609198A0 (en) Use of non-peptidyl compounds for the treatment of insulin related ailments
GB0103668D0 (en) Methods and clinical devices for the inhibition or prevention of mammalian cell growth
AU2003280298A1 (en) Methods for the biological treatment of gas
AU2003229284A1 (en) Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur
AU1025001A (en) Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis
IL160971A0 (en) Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
AU2002349271A1 (en) Use of active substances for the prophylaxis and/or treatment of diseases caused by cell growth disturbances and test system for discovery of said active substances
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
AU2182800A (en) Use of inhibitors of gag synthesis for the treatment of corneal haze
AU2003205751A1 (en) Plant growth modulation by drl1 and other proteins of the elongator complex
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection
AU1393801A (en) Method for the treatment and/or prophylaxis of diseases caused by il-12
AU2002353146A1 (en) Cell culture system and methods of use
AU2002338794A1 (en) Use of mannosamine derivatives for the stimulation of neurite growth
AU2002356389A1 (en) Use of bard1 inhibitors for promoting cell survival
AU2001262520A1 (en) Combined preparation for the treatment of neoplasic diseases
AU2002337618A1 (en) Process and installation for the treatment of biological studies
AU2003255750A1 (en) Method for the preparation, purification and differentiation of neurospheres from mammalian stem cells
AU2354301A (en) Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and -cyanamides for the treatment of diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase